Globus Medical will showcase its products and innovations at the AAOS Annual Meeting in San Diego from March 10-14, 2025. Globus Medical, Inc. announced its participation in the 2025 Annual ...

By bringing these developments to the forefront, Globus Medical demonstrates its commitment to innovation and excellence in orthopedic care, aiming to provide solutions that improve surgical ...

Globus Medical has been actively pursuing growth through strategic acquisitions and product innovation. The company’s recent acquisition of Nevro Corp for $250 million represents a significant ...

BTIG analysts have downgraded Globus Medical from "Buy" to "Neutral" amid fears surrounding the company's Spine business.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $77.5, a high ...

Globus Medical, a leader in musculoskeletal solutions, has historically focused on rapid product development and innovation. The recent acquisition of NuVasive, a spine surgery technology firm ...

Globus Medical closed 2024 on a strong note with record financial performance, driven by sales growth, innovative product launches, and strategic acquisitions. The integration of Nevro Corporation ...

Globus Medical (NYSE:GMED) announced that its board of directors authorized a share repurchase program totaling up to $500 ...